drugset / Trial / NCT07828197
A Pharmacokinetic Study of HDM1005 Injection at Different Injection Sites
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the relative bioavailability of a single subcutaneous injection of HDM1005 solution at different injection sites (upper arm and thigh)by using the abdomen subcutaneous injection as a control.
Timeline
- Start
- 2026-09-03
- Primary completion
- 2026-10
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HDM1005 | Unknown | 2 mg | Subcutaneous |